| Name | Title | Contact Details |
|---|
Alara is a Fremont, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
John J. Morgan and David R. White founded MorganWhiteGroup, Inc. in 1987. The business started out primarily focusing on payroll deduction of supplemental insurance products, and has grown into what is today, a holding company made up of 6 wholly owned subsidiaries. The MorganWhiteGroup of companies now includes: Two sales agencies, MWG Employer Services and MWG Senior Healthcare, two third-party administrators (TPAs), MorganWhite Administrators, Inc. and MorganWhite Administrators International, a marketing agency, MWG Marketing, and a Reinsurance Intermediary, MWG Reinsurance, Inc. Our success since 1987 has been achieved by delivering insurance products to the marketplace that cannot be found anywhere else. Our company's guiding principal has been to find a market that is either under-served or not served at all and design a product to fit that market. At MorganWhiteGroup, we look forward to the challenge of solving customers’ medical, dental and vision insurance needs today, and in the future. We are committed to making the investment in technology, equipment, and personnel to provide our customers with the latest, most up to date tools available, to solve their insurance needs.
International Society for Medical Publication is a Briarcliff Manor, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Pro-MED is a Coral Springs, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
As the nation’s leading community oncology alliance, RainTree Oncology Services assists our member practices in achieving better and more cost effective treatment of oncology patients while creating new streams of revenue for community oncology practices through. Creating a unique aggregated data compilation and analytic platform allowing RainTree members to develop and evaluate care pathways to improve patient care and outcomes while reducing costs to the health care system; and Developing commercial relationships accelerating innovative oncology treatments and payer arrangements while optimizing oncology patient care and advancing the science of oncology.